New FDA tri­al in­no­va­tion cen­ter launch­es with demon­stra­tion to in­crease in­dus­try in­ter­ac­tions

The FDA on Mon­day launched a new hub fo­cused on in­no­vat­ing in clin­i­cal tri­als as part of wider ef­forts to make drug de­vel­op­ment more ef­fi­cient.

The new Cen­ter for Clin­i­cal Tri­al In­no­va­tion (C3TI) will fo­cus on im­ple­ment­ing lessons al­ready gleaned from CDER’s work in the area and will give clin­i­cal tri­al spon­sors ad­di­tion­al ac­cess to staff to dis­cuss tri­al de­signs. Specif­i­cal­ly, the new hub will fo­cus on keep­ing spon­sors up to speed with cur­rent in­no­va­tions, bol­ster­ing tri­al par­tic­i­pant di­ver­si­ty, and im­prov­ing clin­i­cal tri­al da­ta.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.